|
Advances in targeted therapies V
F C Breedveld, J R Kalden, and J S Smolen
Ann Rheum Dis 2003; 62 (Supplement 2
): 1. doi:10.1136/ard.62.suppl_2.ii1
[Extract]
[Full text]
[PDF]
[Request Permissions]
|
|
|
|
Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other immune mediated inflammatory diseases (May 2003)
D E Furst, F C Breedveld, J R Kalden, J S Smolen, G R Burmester, M Dougados, P Emery, A Gibofsky, A F Kavenaugh, E C Keystone, L Klareskog, A S Russell, L B A van de Putte, and M H Weisman
Ann Rheum Dis 2003; 62 (Supplement 2
): 2. doi:10.1136/ard.62.suppl_2.ii2
[Extract]
[Full text]
[PDF]
[Request Permissions]
|
|
|
|
D van der Heijde and R Landewé
Ann Rheum Dis 2003; 62 (Supplement 2
): 10. doi:10.1136/ard.62.suppl_2.ii10
[Abstract]
[Full text]
[PDF]
[Request Permissions]
|
|
|
|
M C Hochberg, J K Tracy, M Hawkins-Holt, and R H Flores
Ann Rheum Dis 2003; 62 (Supplement 2
): 13. doi:10.1136/ard.62.suppl_2.ii13
[Abstract]
[Full text]
[PDF]
[Request Permissions]
|
|
|
|
J J Oppenheim, A Biragyn, L W Kwak, and D Yang
Ann Rheum Dis 2003; 62 (Supplement 2
): 17. doi:10.1136/ard.62.suppl_2.ii17
[Abstract]
[Full text]
[PDF]
[Request Permissions]
|
|
|
|
J F Kinsel and M V Sitkovsky
Ann Rheum Dis 2003; 62 (Supplement 2
): 22. doi:10.1136/ard.62.suppl_2.ii22
[Abstract]
[Full text]
[PDF]
[Request Permissions]
|
|
|
|
F Melchers
Ann Rheum Dis 2003; 62 (Supplement 2
): 25. doi:10.1136/ard.62.suppl_2.ii25
[Abstract]
[Full text]
[PDF]
[Request Permissions]
|
|
|
|
A Silman, D Symmons, D G I Scott, and I Griffiths
Ann Rheum Dis 2003; 62 (Supplement 2
): 28. doi:10.1136/ard.62.suppl_2.ii28
[Abstract]
[Full text]
[PDF]
[Request Permissions]
|
|
|
|
M Flendrie, M C W Creemers, P M J Welsing, A A den Broeder, and P L C M van Riel
Ann Rheum Dis 2003; 62 (Supplement 2
): 30. doi:10.1136/ard.62.suppl_2.ii30
[Abstract]
[Full text]
[PDF]
[Request Permissions]
|
|
|
|
Advances in targeted therapy: safety of biological agents
E C Keystone
Ann Rheum Dis 2003; 62 (Supplement 2
): 34. doi:10.1136/ard.62.suppl_2.ii34
[Extract]
[Full text]
[PDF]
[Request Permissions]
|
|
|
|
S Ehlers
Ann Rheum Dis 2003; 62 (Supplement 2
): 37. doi:10.1136/ard.62.suppl_2.ii37
[Abstract]
[Full text]
[PDF]
[Request Permissions]
|
|
|
|
F F Mohammed, D S Smookler, and R Khokha
Ann Rheum Dis 2003; 62 (Supplement 2
): 43. doi:10.1136/ard.62.suppl_2.ii43
[Abstract]
[Full text]
[PDF]
[Request Permissions]
|
|
|
|
Role of interleukin 18 in rheumatoid arthritis
F Y Liew, X-Q Wei, and I B McInnes
Ann Rheum Dis 2003; 62 (Supplement 2
): 48. doi:10.1136/ard.62.suppl_2.ii48
[Extract]
[Full text]
[PDF]
[Request Permissions]
|
|
|
|
New strategies to control inflammatory synovitis: interleukin 15 and beyond
I B McInnes, J A Gracie, M Harnett, W Harnett, and F Y Liew
Ann Rheum Dis 2003; 62 (Supplement 2
): 51. doi:10.1136/ard.62.suppl_2.ii51
[Extract]
[Full text]
[PDF]
[Request Permissions]
|
|
|
|
B cell therapy for rheumatoid arthritis: the rituximab (anti-CD20) experience
T Shaw, J Quan, and M C Totoritis
Ann Rheum Dis 2003; 62 (Supplement 2
): 55. doi:10.1136/ard.62.suppl_2.ii55
[Extract]
[Full text]
[PDF]
[Request Permissions]
|
|
|
|
Angiogenesis as a target in rheumatoid arthritis
A E Koch
Ann Rheum Dis 2003; 62 (Supplement 2
): 60. doi:10.1136/ard.62.suppl_2.ii60
[Extract]
[Full text]
[PDF]
[Request Permissions]
|
|
|
|
Interleukin 6 receptor as a target for the treatment of rheumatoid arthritis
E Choy
Ann Rheum Dis 2003; 62 (Supplement 2
): 68. doi:10.1136/ard.62.suppl_2.ii68
[Extract]
[Full text]
[PDF]
[Request Permissions]
|
|
|
|
4 Integrin blockade in inflammatory bowel disease
S Ghosh
Ann Rheum Dis 2003; 62 (Supplement 2
): 70. doi:10.1136/ard.62.suppl_2.ii70
[Extract]
[Full text]
[PDF]
[Request Permissions]
|
|
|
|
A H Reddi
Ann Rheum Dis 2003; 62 (Supplement 2
): 73. doi:10.1136/ard.62.suppl_2.ii73
[Abstract]
[Full text]
[PDF]
[Request Permissions]
|
|
|
|
Therapeutic targets in osteoarthritis: from today to tomorrow with new imaging technology
J-P Pelletier and J Martel-Pelletier
Ann Rheum Dis 2003; 62 (Supplement 2
): 79. doi:10.1136/ard.62.suppl_2.ii79
[Extract]
[Full text]
[PDF]
[Request Permissions]
|
|
|
|
Signalling in osteoclasts and the role of Fos/AP1 proteins
E F Wagner and K Matsuo
Ann Rheum Dis 2003; 62 (Supplement 2
): 83. doi:10.1136/ard.62.suppl_2.ii83
[Extract]
[Full text]
[PDF]
[Request Permissions]
|
|
|
|
D Hammaker, S Sweeney, and G S Firestein
Ann Rheum Dis 2003; 62 (Supplement 2
): 86. doi:10.1136/ard.62.suppl_2.ii86
[Abstract]
[Full text]
[PDF]
[Request Permissions]
|
|
|
|
Prospects for the development of small molecular weight compounds to replace anti-tumour necrosis factor biological agents
B Foxwell, E Andreakos, F Brennan, M Feldmann, C Smith, and M Conron
Ann Rheum Dis 2003; 62 (Supplement 2
): 90. doi:10.1136/ard.62.suppl_2.ii90
[Extract]
[Full text]
[PDF]
[Request Permissions]
|
|
|
|
Rheumatoid arthritis in 2003: where are we now with treatment?
M E Weinblatt
Ann Rheum Dis 2003; 62 (Supplement 2
): 94. doi:10.1136/ard.62.suppl_2.ii94
[Extract]
[Full text]
[PDF]
[Request Permissions]
|
|
|